logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9834520 B1

PDFFull Text
Date of Patent:
Dec. 05, 2017

Filed:

Mar. 13, 2014

Heterocyclic compound

Applicant:

Takeda Pharmaceutical Company Limited, Osaka-shi, Osaka, JP;

Inventors:

Satoshi Yamamoto, Fujisawa, JP;

Junya Shirai, Fujisawa, JP;

Yoshiyuki Fukase, Fujisawa, JP;

Ayumu Sato, Fujisawa, JP;

Mitsunori Kouno, Fujisawa, JP;

Yoshihide Tomata, Fujisawa, JP;

Atsuko Ochida, Fujisawa, JP;

Kazuko Yonemori, Fujisawa, JP;

Tsuneo Oda, Fujisawa, JP;

Tomoya Yukawa, Fujisawa, JP;

Assignee:

Takeda Pharmaceutical Company Limited, Osaka, JP;

Attorneys:

Lisa V. Mueller

Michael Best & Friedrich LLP

Primary Examiner:

Shengjun Wang

Int. Cl.
CPC ...
A61K 31/517 (2006.01); C07D 239/72 (2006.01); C07D 239/96 (2006.01); C07D 403/12 (2006.01); C07D 401/12 (2006.01); C07D 409/12 (2006.01); C07D 239/80 (2006.01); C07D 413/12 (2006.01); C07D 417/12 (2006.01); C07D 471/04 (2006.01); C07D 265/36 (2006.01); C07D 217/24 (2006.01); C07D 405/06 (2006.01); C07D 475/04 (2006.01); C07F 7/08 (2006.01);
U.S. Cl.
CPC ...
C07D 239/96 (2013.01); C07D 217/24 (2013.01); C07D 239/80 (2013.01); C07D 265/36 (2013.01); C07D 401/12 (2013.01); C07D 403/12 (2013.01); C07D 405/06 (2013.01); C07D 409/12 (2013.01); C07D 413/12 (2013.01); C07D 417/12 (2013.01); C07D 471/04 (2013.01); C07D 475/04 (2013.01); C07F 7/0812 (2013.01);
Abstract

The present invention provides a heterocyclic compound having an RORγt inhibitory action. The present invention relates to a compound represented by the formula (I): whereinAr is a the partial structure (1) to the partial structure (5),Q is a bivalent group selected from the group consisting of (Ia)-(If), andB is a ring optionally having substituent(s),or a salt thereof.

Find Patent Forward Citations

Loading…